Yes, thanks. I posted the same image last week.
I think you're missing my point. We knew months ago that societal were successful in delivering GMP RC220. This work should have been tendered before this confirmation was received and these agreements should have been executed before the engineering batch was shipped.
I don't want Attentive to advise of a safe starting dose before the company starts thinking about ethics approval.
Ann: RC220 Toxicology and Safety Pharmacology Studies Initiated, page-43
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.94 |
Change
0.055(2.92%) |
Mkt cap ! $330.4M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.96 | $1.85 | $333.0K | 174.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3105 | $1.94 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.95 | 7574 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |